Literature DB >> 23100345

Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany.

Steffen Geis1, Christiane Prifert, Benedikt Weissbrich, Nicola Lehners, Gerlinde Egerer, Christoph Eisenbach, Udo Buchholz, Elisabeth Aichinger, Peter Dreger, Kai Neben, Ulrich Burkhardt, Anthony D Ho, Hans-Georg Kräusslich, Klaus Heeg, Paul Schnitzler.   

Abstract

In 2011 and 2012, a large outbreak of respiratory syncytial virus (RSV) infections affecting 57 laboratory-confirmed patients occurred in an adult hematology unit in Heidelberg, Germany. During the outbreak investigation, we performed molecular genotyping of RSV strains to differentiate between single versus multiple introductions of the virus into the unit. Furthermore, we assessed the time of viral shedding of consecutive samples from the patients in order to better understand the possible impact of prolonged shedding for outbreak control management. We used subtype-specific reverse transcription-PCR on nasopharyngeal and bronchoalveolar specimens for routine diagnostics and for measuring the viral shedding period. Samples of 47 RSV-infected patients involved in the outbreak were genotyped by sequence analysis and compared to samples from RSV-infected hospitalized children representing the timing of the annual RSV epidemic in the community. Molecular investigation of the virus strains from clinical samples revealed a unique cluster with identical nucleotide sequences of RSV type A (RSV A outbreak strain) for 41 patients, while 3 patients were infected with different RSV A (nonoutbreak) strains and three other patients with RSV type B. Outbreak strains were identified in samples from November 2011 until January 2012, while nonoutbreak strains were from samples coinciding with the community epidemic in February and March 2012. Median duration of viral shedding time was 24.5 days (range, 1 to 168 days) with no difference between outbreak and nonoutbreak strains (P = 0.45). Our investigation suggests a single introduction of the RSV A outbreak strain into the unit that spread among the immunocompromised patients. Prolonged viral shedding may have contributed to nosocomial transmission and should be taken into account in the infection control management of RSV outbreaks in settings with heavily immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100345      PMCID: PMC3536189          DOI: 10.1128/JCM.02151-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

Review 1.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

2.  Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides.

Authors:  Alfonsina Trento; Mónica Galiano; Cristina Videla; Guadalupe Carballal; Blanca García-Barreno; José A Melero; Concepción Palomo
Journal:  J Gen Virol       Date:  2003-11       Impact factor: 3.891

3.  Comparative virulence of respiratory syncytial virus subgroups A and B.

Authors:  C E Taylor; S Morrow; M Scott; B Young; G L Toms
Journal:  Lancet       Date:  1989-04-08       Impact factor: 79.321

4.  Molecular epidemiology of outbreak of respiratory syncytial virus within bone marrow transplantation unit.

Authors:  G S Taylor; I B Vipond; E O Caul
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.

Authors:  A J McCarthy; H M Kingman; C Kelly; G S Taylor; E O Caul; D Grier; J Moppett; A B Foot; J M Cornish; A Oakhill; C G Steward; D H Pamphilon; D I Marks
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

6.  Modes of transmission of respiratory syncytial virus.

Authors:  C B Hall; R G Douglas
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406

Review 7.  Respiratory syncytial virus infection in adults.

Authors:  A R Falsey; E E Walsh
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

8.  An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment.

Authors:  A Abdallah; K E Rowland; S K Schepetiuk; L B To; P Bardy
Journal:  Bone Marrow Transplant       Date:  2003-07       Impact factor: 5.483

9.  Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes.

Authors:  S McCann; J L Byrne; M Rovira; P Shaw; P Ribaud; S Sica; L Volin; E Olavarria; S Mackinnon; P Trabasso; M T VanLint; P Ljungman; K Ward; P Browne; A Gratwohl; A F Widmer; C Cordonnier
Journal:  Bone Marrow Transplant       Date:  2004-03       Impact factor: 5.483

10.  Correlation between respiratory syncytial virus genotype and severity of illness.

Authors:  Richard A Martinello; Martin D Chen; Carla Weibel; Jeffrey S Kahn
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226

View more
  24 in total

1.  Evaluation of the Roche antigen rapid test and a cell culture-based assay compared to rRT- PCR for the detection of SARS-CoV-2: A contribution to the discussion about SARS-CoV-2 diagnostic tests and contagiousness.

Authors:  Jacqueline Steinlin-Schopfer; Maria Teresa Barbani; Richard Kamgang; Martina Zwahlen; Franziska Suter-Riniker; Ronald Dijkman
Journal:  J Clin Virol Plus       Date:  2021-05-09

2.  Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level.

Authors:  Vahid Salimi; Mariana Viegas; Alfonsina Trento; Charles N Agoti; Larry J Anderson; Vasanthi Avadhanula; Justin Bahl; Louis Bont; J Rodney Brister; Patricia A Cane; Mónica Galiano; Barney S Graham; Eneida L Hatcher; Orienka Hellferscee; David M Henke; Siddhivinayak Hirve; Sandra Jackson; Els Keyaerts; Leyla Kragten-Tabatabaie; Stephen Lindstrom; Inne Nauwelaers; D James Nokes; Peter J Openshaw; Teresa C Peret; Pedro A Piedra; Kaat Ramaekers; Annabel Rector; Nídia Sequeira Trovão; Anne von Gottberg; Maria Zambon; Wenqing Zhang; Thomas C Williams; Ian G Barr; Ursula J Buchholz
Journal:  Emerg Infect Dis       Date:  2021-06       Impact factor: 6.883

3.  Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection.

Authors:  Matthew B Rogers; Timothy Song; Robert Sebra; Benjamin D Greenbaum; Marie-Eve Hamelin; Adam Fitch; Alan Twaddle; Lijia Cui; Edward C Holmes; Guy Boivin; Elodie Ghedin
Journal:  MBio       Date:  2015-04-07       Impact factor: 7.867

4.  Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center.

Authors:  Helen Y Chu; Janet A Englund; Sara Podczervinski; Jane Kuypers; Angela P Campbell; Michael Boeckh; Steven A Pergam; Corey Casper
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-06       Impact factor: 5.742

5.  Contributing and Terminating Factors of a Large RSV Outbreak in an Adult Hematology and Transplant Unit.

Authors: 
Journal:  PLoS Curr       Date:  2014-09-19

6.  Novel respiratory syncytial virus (RSV) genotype ON1 predominates in Germany during winter season 2012-13.

Authors:  Julia Tabatabai; Christiane Prifert; Johannes Pfeil; Jürgen Grulich-Henn; Paul Schnitzler
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

7.  Clinical characterisation and phylogeny of respiratory syncytial virus infection in hospitalised children at Red Cross War Memorial Children's Hospital, Cape Town.

Authors:  Regina Oladokun; Rudzani Muloiwa; Nei-Yuan Hsiao; Ziyaad Valley-Omar; James Nuttall; Brian Eley
Journal:  BMC Infect Dis       Date:  2016-05-31       Impact factor: 3.090

8.  Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Authors:  Anne-Gaëlle Goubet; Agathe Dubuisson; Laurence Zitvogel; Lisa Derosa; Arthur Geraud; François-Xavier Danlos; Safae Terrisse; Carolina Alves Costa Silva; Damien Drubay; Lea Touri; Marion Picard; Marine Mazzenga; Aymeric Silvin; Garett Dunsmore; Yacine Haddad; Eugenie Pizzato; Pierre Ly; Caroline Flament; Cléa Melenotte; Eric Solary; Michaela Fontenay; Gabriel Garcia; Corinne Balleyguier; Nathalie Lassau; Markus Maeurer; Claudia Grajeda-Iglesias; Nitharsshini Nirmalathasan; Fanny Aprahamian; Sylvère Durand; Oliver Kepp; Gladys Ferrere; Cassandra Thelemaque; Imran Lahmar; Jean-Eudes Fahrner; Lydia Meziani; Abdelhakim Ahmed-Belkacem; Nadia Saïdani; Bernard La Scola; Didier Raoult; Stéphanie Gentile; Sébastien Cortaredona; Giuseppe Ippolito; Benjamin Lelouvier; Alain Roulet; Fabrice Andre; Fabrice Barlesi; Jean-Charles Soria; Caroline Pradon; Emmanuelle Gallois; Fanny Pommeret; Emeline Colomba; Florent Ginhoux; Suzanne Kazandjian; Arielle Elkrief; Bertrand Routy; Makoto Miyara; Guy Gorochov; Eric Deutsch; Laurence Albiges; Annabelle Stoclin; Bertrand Gachot; Anne Florin; Mansouria Merad; Florian Scotte; Souad Assaad; Guido Kroemer; Jean-Yves Blay; Aurélien Marabelle; Frank Griscelli
Journal:  Cell Death Differ       Date:  2021-07-06       Impact factor: 15.828

9.  Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.

Authors:  Yae-Jean Kim; Katherine A Guthrie; Alpana Waghmare; Edward E Walsh; Ann R Falsey; Jane Kuypers; Anne Cent; Janet A Englund; Michael Boeckh
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226

10.  Evaluation of a virucidal quantitative carrier test for surface disinfectants.

Authors:  Holger F Rabenau; Jochen Steinmann; Ingrid Rapp; Ingeborg Schwebke; Maren Eggers
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.